UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000023065
Receipt No. R000026585
Scientific Title An intergroup phase III trial of Ramucirumab plus Irinotecan in third or more line Beyond progression after Ramucirumab for Advanced Gastric cancer.
Date of disclosure of the study information 2016/07/13
Last modified on 2018/07/27 20:17:34

No. Disposal Last modified on Item of update
1 Insert 2016/07/07 19:58:05
2 Update 2016/11/29 22:05:28 Public title
Public title
3 Update 2017/02/21 18:22:54 Recruitment status
Anticipated trial start date
4 Update 2017/06/30 20:08:58 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
5 Update 2018/07/27 20:16:14 Recruitment status
6 Update 2018/07/27 20:17:34 UMIN ID1

Contact us.